Neuroregeneration and plasticity: a review of the physiological mechanisms for achieving functional recovery postinjury by Nagappan, Palaniappan Ganesh et al.
REVIEW Open Access
Neuroregeneration and plasticity: a review
of the physiological mechanisms for
achieving functional recovery postinjury
Palaniappan Ganesh Nagappan1, Hong Chen2* and De-Yun Wang3
Abstract
Neuronal networks, especially those in the central nervous system (CNS), evolved to support extensive functional
capabilities while ensuring stability. Several physiological “brakes” that maintain the stability of the neuronal
networks in a healthy state quickly become a hinderance postinjury. These “brakes” include inhibition from the
extracellular environment, intrinsic factors of neurons and the control of neuronal plasticity. There are distinct
differences between the neuronal networks in the peripheral nervous system (PNS) and the CNS. Underpinning
these differences is the trade-off between reduced functional capabilities with increased adaptability through the
formation of new connections and new neurons. The PNS has “facilitators” that stimulate neuroregeneration and
plasticity, while the CNS has “brakes” that limit them. By studying how these “facilitators” and “brakes” work and
identifying the key processes and molecules involved, we can attempt to apply these theories to the neuronal
networks of the CNS to increase its adaptability. The difference in adaptability between the CNS and PNS leads to a
difference in neuroregenerative properties and plasticity. Plasticity ensures quick functional recovery of abilities in
the short and medium term. Neuroregeneration involves synthesizing new neurons and connections, providing
extra resources in the long term to replace those damaged by the injury, and achieving a lasting functional
recovery. Therefore, by understanding the factors that affect neuroregeneration and plasticity, we can combine their
advantages and develop rehabilitation techniques. Rehabilitation training methods, coordinated with
pharmacological interventions and/or electrical stimulation, contributes to a precise, holistic treatment plan that
achieves functional recovery from nervous system injuries. Furthermore, these techniques are not limited to limb
movement, as other functions lost as a result of brain injury, such as speech, can also be recovered with an
appropriate training program.
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Background
According to the Spinal Cord Injury (SCI) Facts and Fig-
ures at a Glance, released by the National Spinal Cord
Injury Statistical Centre in 2019, there are approximately
17,000 new cases of SCI each year in the United States
[1, 2]. Per the Defense and Veterans Brain Injury Center
(DVBIC) data, 413,858 individuals within the Depart-
ment of Defense in the United States sustained a trau-
matic brain injury (TBI) between 2001 and 2019 [3],
with more than one-third having been exposed to a blast
event [4, 5]. These two statistics demonstrate the magni-
tude of the different types of nervous system injuries
that veterans are susceptible to. The nervous system
comprises the central nervous system (CNS) and the
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peripheral nervous system (PNS). The CNS consists of
the brain and spinal cord, while the PNS consists of cra-
nial and spinal nerves along with their associated gan-
glia. The PNS has an intrinsic ability for regeneration
and repair; however, the CNS is largely unable to self-
repair. Moreover, the intrinsic regenerative ability is self-
limiting, depending on the characteristics and type of in-
jury, such as those induced by chemotherapy [6].
Current treatment options available after injury to the
CNS are limited, often consisting of palliative care [7].
The reasons for these limited options are due to both
the intracellular and extracellular factors within the CNS
that hinder regeneration. This review investigates the
physiological reactions to injuries to the nervous system
and attempts by the system to recover to its prior func-
tional state. By comparing the differences in the PNS
and CNS, we can help elucidate these mechanisms.
Neuroregeneration and plasticity changes occur first
at the regional level in an attempt to revive immedi-
ate function and bridge the short-term requirements
of the nervous system. While this is occurring, the
lengthy process of restoring function with greater per-
manence occurs at a cellular level. When these pro-
cesses are combined with rehabilitation techniques
[8], a synergistic effect leads to the functional recov-
ery of nervous system injuries sustained in the field.
Neuroregeneration in the PNS and CNS
Neuroregeneration in the PNS
The PNS and CNS have several differences in terms of the
balance between “facilitators” and “brakes”, which are illus-
trated in Fig. 1. The PNS has significant regenerative prop-
erties, both morphological and functional. Above and
below the lesion, sprouting occurs to make connections,
which eventually leads to neuroregeneration. Lesions can
result in the activation of otherwise silent connections with
ganglia below the lesion site, leading to functional
resolution.
The initial injury leads to acute axonal degeneration
(AAD), causing the distal and proximal ends to separate
within 30min of the injury [9]. This is a crucial process
initiated by the initial influx of calcium [10], as seen in
Fig. 2, that begins the entire process of degeneration
through the preliminary clearing of the damaged parts of
an axon. Dystrophic bulb structures then begin to form
at both terminals while the membranes are sealed. Fol-
lowing this formation, sprouting has been observed to
occur, which forms the growth cone. Upon contact with
adhesion molecules in the environment, the growth cone
then orientates towards the regions with adhesion mole-
cules [11]. This steering of the growth cones towards
areas with high concentrations of adhesion molecules
provides a suitable means of reconnecting both axonal
Fig. 1 Extrinsic and intrinsic factors that affect neuroregeneration in the central and peripheral nervous systems. PTEN. Phosphatase and tensin
homolog; SOCS3. Suppressor of cytokine signaling 3; NGF. Nerve growth factor; MAG. Myelin-associated glycoprotein; Omgp.
Oligodendrocyte.myelin glycoprotein; CSPG. Chondroitin sulfate proteoglycans; KSPG. Keratin sulfate proteoglycans
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ends. Adhesion molecules can be either membrane-
bound (e.g., Ephrin and Semaphorin) or diffusible factors
(e.g., Sema3A, NGF, Netrin-1, Reelin and Slit) [12, 13].
Growth cones derive their building materials from 4
sources: the environment; transport vesicles initially lo-
calizing to axon terminals; mRNAs translated locally to
synthesize the proteins; and recycled axonal molecules
such as actin and tubulin [14].
As a result of injury to the axon, axonal permeability
to calcium is temporarily increased, lasting minutes. This
prolonged access creates a high-concentration calcium
pulse that activates several factors, including calpains
[15], as shown in Fig. 2. The initial part of the calcium
influx enables the axon to seal itself and form a retrac-
tion bulb, while the later part of the influx activates cal-
pains that digest the submembranous spectrin cortex.
This digestion facilitates successful regeneration of the
axon post-injury as it provides access for transport
vesicles to reach the surface of the axon tip to deposit
new receptors and membrane components. Without this
access, these transport vesicles would accumulate within
the retraction bulb, resulting in a static end bulb [16].
The other key signaling pathway activated by the cal-
cium pulse is MapKKK dlk-1, which is essential for the
formation of growth cones and thus regeneration [17],
as shown in Fig. 2.
To sustain the development of growth cones, large-
scale protein synthesis needs to occur. The axons them-
selves contain approximately 3000 mRNAs, which are
specific for axonal maintenance, repair and regeneration.
The axons also contain ribosomes and Golgi-like struc-
tures that produce proteins locally [18]. In addition, cal-
cium influx induces several important effects. It
upregulates the translation of importins and RanBP,
which is transported through retrograde action, picking
up Vimentin fragments and Erk and inducing their
Fig. 2 Cascade of reactions from a calcium burst and methods of activating regeneration-associated genes (RAGs). MAPKKK dlk1. Mitogen-
activated protein kinase kinase kinase dlk-1; pErk. Phosphorylated extracellular signal-regulated protein kinases; HDAC5. Histone Deacetylase 5;
RAGs. Regeneration associated genes; PTEN. Phosphatase and tensin homolog; PI3K. Phosphoinositide 3-kinases; AKT. Protein kinase B; mTORC1.
Mammalian target of rapamycin complex 1 or mechanistic target of rapamycin complex 1; SOCS3. Suppressor of cytokine signaling 3; JAK/STAT 3.
Janus kinase/signal transducer and activator of transcription 3
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transport to the nucleus to trigger the expression of
regeneration-associated genes (RAGs) [19]. The calcium
pulse also causes a cytoplasmic shift of HDAC5 to leave
the nucleus via PKCμ. This translocation allows for pre-
viously suppressed genes to be activated via acetylation
of histones, stimulating the synthesis of RAG-associated
transcription factors such as c-jun and c-fos. HDAC5, as
a result of its cytoplasmic translocation, is transported to
the growth cone, where it helps to promote axon growth
via microtubule deacetylation [20]. Furthermore, RAGs
facilitate axon priming, which is known as a condition-
ing effect, for faster regeneration in the event of future
injuries. These are some of the key aspects of the post-
injury status that occurs within an axon to support
growth cone formation and nerve regeneration in the
axons proximal to the lesion.
Modifications occur in the axon distal site prior to re-
connection with the proximal end. The axon beyond the
lesion rapidly degenerates in an active process – Waller-
ian degeneration – and is triggered by depletion of the
rapidly degrading NMNAT2 as controlled by SARM1
[21, 22]. Within 48 h, the myelin sheaths begin to separ-
ate at the Schimdt-Lanterman incisures before forming
bead-like structures. Initially, Schwann cells phagocytose
myelin debris [23] while waiting for macrophages to re-
spond to secreted cytokines and chemokines. At the
three-week point after the injury, the influx of macro-
phages reaches its peak, clearing the remaining debris
using opsonins, complement antibodies, and pentraxins
[24]. The purpose of this influx could be to generate a
blank slate upon which regeneration can begin without
interference from fragments of older material, thus fa-
cilitating neuroregeneration.
Once the myelin debris from the distal axons have
been cleared, the process of regeneration can begin as
the “brakes” have been lifted. The expression of nerve
growth factor (NGF) mRNA is upregulated five- to
seven-fold within a period of 2 weeks. This increase can
be attributed directly to the effects of nerve fibroblasts
and Schwann cells [25] and indirectly to macrophages
that stimulate these cells with macrophage-derived
interleukin-1 [26]. Other neurotrophic factors released
include brain-derived growth factor, insulin-like growth
factor, fibroblast growth factor, NT3, artemin and glial
cell line-derived neurotrophic factor. Damage-related
signaling molecules, such as p38 MAPK, activate the
transcription factor c-jun, which in turn induces
Schwann cells to change into specialized repair cells –
Bands of Bungner within the basal laminar tube [27];
these cells provide structural guidance to further en-
hance regeneration, without which regeneration would
not be possible [28].
A time limit has been observed in several cases, prov-
ing that regeneration can occur only within a narrow
window after injury. Regeneration proceeds in the PNS
at 1 mm per day and can bridge gaps of 1 cm. Within 2–
3 months, Schwann cells lose their permissiveness to re-
generation signaling. Thus, for a long limb, such as the
arm or leg, only the proximal limb may be reinnervated,
with the chances for distal reinnervation dropping dras-
tically [29, 30]. Notably, the muscle cells need not be at
the muscle endplate for reinnervation. Only the endplate
extracellular matrix containing S-laminin and agrin, the
remaining Schwann cells and capping cells are required
to provide guidance for reinnervation [31].
It is a clinically observable fact that the regenerative
capacity of the nervous system declines with age, corre-
sponding to the residual functional reserve of individ-
uals. Painter and colleagues replicated this phenomenon
in aged mice. However, they found that it was not the
loss of regenerative ability of the axons that caused the
decline; instead, it was the decline of glial function that
caused the loss. Ageing glia results in the slow clearance
of myelin debris, causing slower Wallerian degeneration.
This impaired Wallerian degeneration can thus lead to
an overall impaired regenerative capacity of the nervous
system [32, 33].
The high influx of calcium as described above and in
Fig. 2, left unchecked, leads to the activation of hydro-
lytic enzymes, exaggerated energy expenditure and im-
paired energy production, eventually resulting in cell
death. This disruption in mitochondrial dynamics has
been implicated in behavioral impairment and cognitive
deficits [34]. In the postinjury state, large amounts of en-
ergy are required for the nerve to return to and be main-
tained at its homeostatic point, with even greater
amounts needed for its self-regeneration. Therefore, sup-
plementing the injured nerve with freshly isolated mito-
chondria provides a means to resolve the cellular energy
crisis and facilitate regeneration [35, 36].
Neuroregeneration in the CNS
CNS injuries have been known to lead to poor progno-
ses because of their inability to regenerate neurons, in
contrast to the response to PNS injuries [37]. Further-
more, this distinction is not seen in all species. Rodents
can restore myelin sheaths to almost all demyelinated
axons [38], and zebrafish are able to efficiently regener-
ate the spinal cord [39, 40]. Why has it been evolution-
arily beneficial for the human CNS to not regenerate?
This state could be a result of the high complexity of the
neuronal networks within the human CNS compared to
that of other species. Whereby adding further neurons
to the already intricate neuronal networks would be
deleterious, as it would risk causing confusion to the sys-
tem by generating foci of inappropriate electrical activity,
similar to short-circuiting an electronic device, thereby
increasing the likelihood of seizures. When the brain is
Nagappan et al. Military Medical Research            (2020) 7:30 Page 4 of 16
healthy, this rigidity and constancy enables the mainten-
ance of normal function. However, under the burden of
disease and injury, these limits become obstructive to
the treatment of patients. To understand how the CNS
can be forced to regenerate, we first must look at the ini-
tial causes of the impairment to this process.
Neuroregeneration in the CNS is turned off because of
the lack of intrinsic CNS axon regeneration ability and
extrinsic inhibition conferred by the CNS environment.
Lack of intrinsic regenerative ability of CNS axons
CNS axons lose their regenerative ability during develop-
ment. Embryonic axons have been found to have a much
greater ability to grow in the CNS than adult axons. Em-
bryonic neurons implanted into the adult CNS can grow
extensively despite the inhibitory environment. Further-
more, embryonic spinal cord precursors have been
shown to accept input from the host axons to fully inte-
grate with the adult cord, acting as a form of relay [41].
This finding demonstrates that an answer for neurore-
generation that overcomes the intrinsic inability of adult
neurons to regenerate lies within the expression of neur-
onal genes.
PTEN and SOCS3 are proteins that have been found to
play roles in inactivating regeneration in CNS neurons by
inhibiting AKT and JAK/STAT signaling, respectively, as
shown in Fig. 2; these two signaling pathways play roles in
promoting survival and growth. The concurrent inactiva-
tion of PTEN and SOCS3 results in the coactivation of
specific gene transcription and protein translation that
permits profuse regeneration of the optic nerve and mod-
erate regeneration of the spinal cord [42, 43]. Importantly,
this regeneration does not induce CNS neurons into a
PNS-like state, as PTEN is similarly expressed and SOCS3
levels are increased in PNS neurons during regeneration
[44, 45]. Nevertheless, increasing mTOR activity via the
deletion of PTEN and SOCS3 enhances axonal regrowth
in PNS neurons [45, 46]. This finding indicates that the
method by which the deletion of PTEN and SOCS3 acts
may involve different growth suppressive mechanisms.
Given the inhibitory environment within the CNS, the
synergistic effects of inhibiting these two different path-
ways remain avenues for inducing neuroregeneration
within the CNS [47, 48].
The axons contain only a subset of the molecules
present in cell bodies. Without the necessary molecules,
regeneration is impaired. Some of the critical molecules
that are absent include integrins, several different growth
factor receptors and ribosomes. Integrins contribute to
the reorganization of extracellular matrix glycoproteins,
while growth factor receptors respond to growth factors
in the environment. In the injured CNS environment,
tenascin, an extracellular matrix glycoprotein, is greatly
upregulated after CNS injury. Unfortunately, adult CNS
neurons do not express a tenascin-binding integrin.
Promising results were observed when α9β1 tenascin-
binding integrin combined with the β1-binding integrin
activator kindlin-1 was expressed in crushed dorsal root
ganglia via transgenic adeno-associated viruses. Kindlin-
1 was necessary to attenuate the inhibition of chondro-
itin sulfate proteoglycans (CSPG). Twelve weeks after
the crush injury, the axons grew from the C6–7 level to
a level above C1, covering a distance of more than 25
mm and 7 spinal levels via the normal pathway. Further
anatomical and electrophysiological analyses demon-
strated that the connections within the spinal cord were
topographically correct. Recovery in response to mech-
anical pressure, thermal pain and ladder-walking tasks
was observed [49].
In addition to the reduction or inhibition of gene ex-
pression during CNS axon maturation, the lack of cer-
tain molecules in the axons can be due to impaired
transport mechanisms to the site of injury. Integrins vir-
ally expressed in the adult rat sensorimotor cortex and
adult red nucleus, but not in the dorsal root ganglia, did
not localize to axons. However, when expressed in devel-
oping rat cortex (postnatal day 5 or 10), clear
localization was observed in the axons of the corpus cal-
losum and internal capsule. In newborn rodent CNS
neurons, integrin permissively travels down the corti-
cospinal tract; however, in adult rodents, integrin trans-
port does not continue past the initial segment, limiting
its function [50]. Therefore, there is a differential ability
in the axonal transport of transmembrane proteins
in vivo, which is dependent on the subtype of the neu-
rons and their age.
Another method of enhancing intrinsic regenerative
ability is to remove any inhibition acting on the pathway.
Many of the CNS inhibitory effects are relayed through
RhoA; an example is shown in Fig. 3. Inactivating RhoA
with the Clostridium botulinum C3 ribosylating exo-
enzyme has been shown [51]. Based on studies on dam-
aged rodent spinal cords with BA210 (cethrin) [52], a
modified inhibitor able to penetrate the dura and cell
membrane, phase I/II clinical trials with 48 patients
demonstrated profound neurological recovery in patients
with cervical spinal cord injury and only modest recov-
ery in those with thoracic spinal cord injury [53–55].
Extrinsic inhibition by the CNS environment
When a CNS axon is placed outside its typical setting,
such as in the permissive environment of a peripheral
nerve, regeneration can be observed to an extent [56].
However, this effect is limited to regeneration in the per-
missive environment of a PNS graft, as it does not extend
to the CNS tissue [57]. This demonstrates that there are
factors within the CNS environment that prevent
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neuroregeneration, and they are attributed to inhibition
induced by glial scars and myelin oligodendrocytes.
(1) Glial scar
Myelin in the CNS is largely derived from oligoden-
drocytes, in contrast to myelin in the PNS, where it is
derived from Schwann cells. A key difference of
Schwann cells and oligodendrocytes is that the latter re-
quire axon signals to survive. In the CNS, space and re-
sources are limited; thus, during development, only the
oligodendrocytes that make contact with axons and re-
ceive axonal signals survive, while the others undergo
apoptosis. This characteristic is carried forward into ma-
turity and contributes to the inhibition observed.
Therefore, upon injury, axonal signals are lost, result-
ing in the oligodendrocytes undergoing either pro-
grammed cell death or senescence. As a result, the
myelin sheaths remain, and their debris is not cleared.
The duration of this process was observed to be as long
as 22 months in rats [58]. As a result, regeneration of
the CNS is hindered due to the lack of clearance. Even-
tually, a reactive cellular process, involving an abnormal
increase in astrocytes (astrogliosis), forms glial scars, fur-
ther hindering the chances of regeneration and
reinnervation.
Another contributing factor to glial scar formation is
the lack of myelin clearance by macrophages and micro-
glia in the CNS. Microglia are the resident macrophages
of the CNS and comprise 10–15% of the cells in the CNS
[59], and therefore, they are also called upon to clear the
myelin from the distal parts of the injured axons. How-
ever, compared to the process in the PNS, recruitment of
these microglia to the injury site takes 3 days longer. Of
those microglia that arrive at the lesion, only a fraction are
transformed to effectively clear the debris [60]. Further-
more, the clearance rates of microglia are lower than those
of macrophages. This difference can be attributed to the
lack of opsonin activity around microglia and the low per-
meability of the blood-brain barrier (BBB), which hinders
macrophage infiltration [23].
The question remains whether glial scar formation is a
byproduct of pathological activity in the CNS or whether
it serves an evolutionary purpose in the maintenance of a
healthy brain. Glial scars consist of reactive astrocytes as
the main component along with microglia, endothelial
cells, fibroblasts and a basal membrane [61]. They prevent
neuronal regeneration by forming a chemical and physical
barrier to axonal extension. Despite creating this barrier,
they have a role in the revascularization of blood capillar-
ies to provide trophic, nutritional and metabolic support
to nerve tissue, with an ultimate function of re-
establishing the chemical and physical integrity of the
CNS. The absence of the glial scar is associated with prob-
lems in the repair of the BBB [62]. Temporarily removing
CNS glia provides a tunnel through which axons can ex-
tend and regenerate temporarily. Removing astrocytes in
the glial scar or the glial scar itself can cause damaging in-
flammation, failed BBB [63] re-formation and problems in
the repair of the BBB [62].
Thus, being able to selectively turn off glial scars and
inhibitory signals in the extracellular matrix would be
useful in neuroregeneration.
Astrocytes constitute a key cell type recognized for
inhibiting axonal regeneration. However, there is great
heterogeneity among astrocytes – comprising both per-
missive and inhibitory astrocyte subpopulations. A com-
parison of these two types showed that the inhibitory
molecules are chondroitin sulfate proteoglycans
(CSPGs), which are upregulated after injury [64, 65].
Fig. 3 Nogo-A mechanism of action. Nogo-A interacts with several receptors, the most important of which are NgR1, LINGO1 and p75/TROY. This
interaction creates a cascade that inhibits neuroregeneration in the nerve cell growth cones. LINGO1. Leucine rich repeat and Immunoglobin-like
domain-containing protein 1; p75. Neurotrophin receptor; TROY. Tumor necrosis factor receptor superfamily, member 19; RhoA. Ras homolog
family member A
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The repeating disaccharides of glucuronic and galactosa-
mine, glycosaminoglycans (CS-GAGs), are covalently
coupled to the protein core of CSPGs and are thought
to be the main inhibitory part of a CSPG. By digesting
this chain with chondroitinase ABC, CSPG inhibition
can be suppressed [66]. Axonal regeneration and a re-
duced inhibition barrier between the CNS tissue and
nerve grafts were observed upon injection of chondroiti-
nase ABC into the CNS. Chondroitinase ABC has also
been shown to improve recovery from spinal cord injuries
[66] when combined with other techniques, such as nerve
guidance conduits, Schwann cell transplants [67] or per-
ipheral nerve autografts [68].
Similar to CSPGs, keratan sulfate proteoglycans
(KSPGs) have N-acetylglucosamine 6-O-sulfotransferase-1
instead of CS-GAGs. Depletion of KSPGs was also found
to suppress the inhibition of nerve regeneration [69].
(2) Myelin
Myelin produced by oligodendrocytes consist of sev-
eral proteins that influence neuroregeneration, each of
which has its own functions. In terms of regeneration,
the NOGO (NI-250) family is key, particularly Nogo-A
[70]. Nogo-A is involved in autoimmune-mediated de-
myelination, which includes multiple sclerosis (MS) and
experimental autoimmune encephalomyelitis (EAE).
Nogo-A can interact with neurons via two main ter-
mini: the amino-Nogo terminus via an unknown recep-
tor and the Nogo-66 terminus through NgR1, p75,
TROY or LINGO1, as shown in Fig. 3. Remyelination is
observed when this inhibitor is antagonized, playing a
major role in the RhoA pathway [71, 72]. The Nogo
receptor, to which the Nogo-66 terminus binds, is also
a receptor of myelin-associated glycoprotein (MAG)
and oligodendrocyte myelin glycoprotein (OMgp).
Treatment with anti-Nogo-A antibody closely followed
by multimodal rehabilitation training showed greater
improvements in functional recovery than either
method alone [73].
As promising as inhibiting NOGO, MAG or OMgp
may be, there have been issues in terms of our under-
standing of their biology. Nogo-A knockouts or triple
knockouts (Nogo-A, MAG and OMgp) both modulate
axonal sprouting; however, they fail to exhibit enhanced
regeneration of axons in the injured spinal cord. There-
fore, they may not play a central role in the failure of re-
generation but instead serve in an accessory or
contributing role [74].
The current issue may be that we are looking for a sil-
ver bullet to treat a central problem in the failure of re-
generation, but given the intricacies of the brain, fine
modulation of several contributory factors may be neces-
sary to maintain existing brain function while promoting
the regrowth of the axons and thus facilitate
neuroregeneration.
Notable inhibitory proteins in the CNS are listed in
Table 1.
Plasticity in the CNS postinjury
Plasticity in the nervous system optimizes neural networks
during ontogeny, phylogenesis, physiological learning and
brain injury. In the context of brain injury, we propose
that neuroplasticity primarily takes the form of cortical re-
mapping. The functions lost as a result of brain damage
can be recovered when the damaged cortex is remapped
to another part of the cortex [80]. This remapping is
achieved through the generation of new circuits that by-
pass lesions and restore function. There are three factors
that contribute to this process: first, distance between the
sprouting of damaged and undamaged axons, with a
shorter separation being advantageous; second, modula-
tion of the existing synaptic strengths; and third, alteration
of the GABAergic interneuron circuitry. The latter two
factors can be induced via metaplastic changes that facili-
tate and regulate long-term potentiation (LTP) and de-
pression (LTD). When coupled with rehabilitation, these
processes can lead to functional recovery of the nervous
system.
In healthy people, plasticity occurs constantly to en-
able memory formation and to cope with functional de-
mands [81]. When rats are trained to retrieve a food
pellet, their distal forelimb motor cortex is enlarged at
the expense of their proximal forelimb motor cortex
[82]. In squirrel monkeys trained to handle small objects
the finger regions are enlarged at the expense of their
wrist and forearm regions [83]. However, when wrist
training replaced the finger training regime, the wrist re-
gions were enlarged, while the finger regions were re-
duced [84]. Therefore, the adult brain is plastic. After
injuries such as strokes and TBIs, specific areas of tissue
are lost that compromise the individual’s ability to carry
out certain functions. The brain thus needs to repriori-
tize the functional needs that are important to the sur-
vival and well-being of the individual. The cortex is
remapped such that the less important functions are di-
minished as the important functions are enhanced. This
cortical remapping occurs alongside the growth of new
connections, which is further enhanced by rehabilitation
leading to improved functional recovery [85]. In the ini-
tial phases after the injury, large areas of the brain have
been found to carry out the function of the damaged
area. Over time, this area becomes focused towards a
single region as a result of cortical remapping [86]. This
enables some functional recovery both in the short and
medium term.
The mechanism underpinning cortical remapping can
be attributed to various forms of functional and
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structural neuroplasticity, importantly metaplasticity
[87–91]. Metaplasticity ensures that synapses are main-
tained within a dynamic range of plasticity [92]. This is
realized by preventing synapses from becoming too
strong or weak to prevent excessive or insufficient exci-
tation, respectively. Based on the Bienenstock, Cooper,
and Munro (BCM) computation model, the LTP and
LTD thresholds are dynamically adjusted based on time-
averaged postsynaptic activity. Metaplasticity works on a
longer timescale than neuromodulation, which involves
neurotransmitters, cytokines and hormones present at
the time of plasticity induction. It may be the process by
which large areas of the brain are initially used to carry
out the function(s) of the damaged area(s) before be-
coming focused on a smaller area. Metaplasticity initially
increases the levels of plasticity throughout the brain to
enable the initial restoration of function, while a long-
term solution is being mapped out at specific regions of
the brain through localized regions of plasticity for par-
ticular functions. Furthermore, intrinsic plasticity is
thought to cooperatively function with synaptic plasticity
to cope with damaged areas of the neuronal network
[91]. The extent to which intrinsic plasticity regulates
neuronal recovery remains a question (e.g., gain, firing
rate of neurons, internal calcium concentration), but
functionally, it may play a role in learning and represent
the intensity of the stimuli in terms of their excitability
levels [93]. Thus, in the damaged brain, this mechanism
can help alleviate the effects of brain damage by bridging
the disparity in firing rates (as a result of missing parts
of the neuronal circuit) through modifications of intrin-
sic excitability [94].
After a spinal cord hemi section in adult rats, bypass
circuits were generated within the spinal cord and brain.
Although fine motor control of the damaged regions
was observed, gross motor control of basic locomotor
function saw substantial recovery as a result of this plas-
ticity. Once again, this demonstrates neuroplasticity’s
important role in the short-term functional recovery of
an individual after injury [95–97].
A crucial aspect that contributed to the functional re-
coveries described above is the rehabilitation process.
Without rehabilitation, the new connections arising from
the increased plasticity would serve little purpose. Re-
habilitation is the crucial process that provides the ne-
cessary stimuli to guide these newly formed circuits into
maturity. Importantly, the type of functional recovery is
dependent on the type of rehabilitation during the
period of increased plasticity. Only the function(s) that
are addressed during rehabilitation showed increased re-
covery, while the functions not addressed during re-
habilitation showed poor recovery [98]. Furthermore,
this rehabilitation process needs to occur immediately
after the initiation of plasticity and not concurrent with
it for the appropriate functional recovery [99].
Therefore, being able to reactivate plasticity in the
adult brain can be very useful in improving functional
recovery and neuroregeneration. Physiologically, there is
a period in the human life span in which the brain is
highly plastic, allowing it to be actively shaped in an
experience-dependent manner. This is termed the crit-
ical period. This period lasts in humans from shortly
after birth to 5 years of age. Children with brain injuries
demonstrate remarkable recovery in motor skills;
Table 1 Proteins in the CNS extracellular matrix that contribute to the inhibition of neuroregeneration after injury
Inhibitory protein Function Complementary receptors
Nogo-A Remyelination inhibitor via the RhoA pathway Nogo-66 terminus: NgR1, p75,
TROY and LINGO1
Amino-Nogo terminus: unknown
MAG Remyelination inhibitor via the RhoA pathway NgR2, GT1b, NgR1, p75, TROY and
LINGO1
OMgp Remyelination inhibitor via the RhoA pathway NgR1
Versican (CSPG2) Important during inflammation as it interacts with inflammatory leukocytes and
inflammatory cells recruiting chemokines. It also stabilizes perineuronal nets to stabilize
synaptic connections.
N-terminus: hyaluronan in the
extracellular matrix (ECM)
C-terminus: Ligands in ECM,
especially tenascin [75]
NI-35 Nonpermissive growth factor in myelin Unknown






In scars in both PNS and CNS injuries Nrp1, Nrp2, L1cam, Nrcam [79]
NgR1 Neuronal Nogo-66 receptor 1, LINGO1 Leucine rich repeat and Immunoglobin-like domain-containing protein 1, p75 neurotrophin receptor, TROY Tumor
necrosis factor receptor superfamily, member 19, RhoA Ras homolog family member A, MAG Myelin-associated glycoprotein, GT1b Trisialoganglioside protein,
OMgp Oligodendrocyte-myelin glycoprotein, CSPG2 chondroitin sulfate proteoglycan core protein 2 or versican, ECM extracellular matix, NI-35 A CNS myelin-
associated neurite growth inhibitor, EphA4 Ephrin type-A receptor 4, Nrp1 Neuropilin 1, Nrp2 Neuropilin 2, L1cam L1 cell adhesion molecule, Nrcam Neuronal cell
adhesion molecule
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however, this is at the expense of cognitive ability, as the
regions critical for cognition were replaced by those fo-
cused on sensorimotor skills [100]. Reactivation of these
windows has implications not only in terms of the focal
damage caused by brain injuries but also in the context
of neurodegenerative disorders such as Alzheimer’s dis-
ease (AD), for which a model has shown memory restor-
ation to an extent [101].
Understanding how plasticity is actuated is important
in the reactivation during critical period windows. In a
cut sciatic nerve, input to the denervated region of the
motor cortex can be recorded hours later. This finding
indicates that previously suppressed nerves are some-
what activated. It has been postulated that, in addition
to normal actively functional nerves, there are intracorti-
cal connections suppressed by GABAergic inhibitory cir-
cuits. These inhibitory circuits modulate and readjust
the motor cortex representations based on the demands
and stressors in place [102]. Therefore, the first step in
short-term functional recovery would be the removal or
modulation of these inhibitory circuits such that new
circuits can be stimulated to compensate for the lost
functions, thus providing a form of circuitry
regeneration.
GABAergic circuits also play a crucial role in creating
the precisely timed generation of action potential, which
is achieved because the average excitatory and inhibitory
signals are similar but not equal [103, 104]. In a long
timescale, inhibitory and excitatory signals appear to
track one another, and an alteration in one leads to an
alteration in the other, producing a stable modification
of the firing characteristics of the neuron [105]. Coord-
inating these alterations in activity at the subcellular, cel-
lular and circuit levels is a set of GABAergic
interneurons [106, 107].
In the medium term, new connections need to be de-
veloped to replace the damaged circuits. This replace-
ment can be done on the dendritic scale by inducing the
generation of new connections between neurons. The
formation of dendritic spines, which are membrane pro-
jections of dendrites, enable the formation of new con-
nections between neurons, stimulating learning to
restore function [108]. Dendritic spine dynamics can
store synaptic information because of their great variety
of shapes, sizes and numbers [109]. Orlando found that
the removal of CSPGs with chondroitinase enhanced
spine dynamics, thus inducing plasticity on the dendritic
scale [110]. This experiment demonstrated that CSPG
plays a significant role in stabilizing neuronal networks
and reducing plasticity.
Later, chondroitinase was been found to also digest a
stabilizing perineuronal net that encases the GABAergic
circuitry during the maturation of neurons. The forma-
tion of this perineuronal net (PNN) coincides with the
end of the critical period of plasticity [111]. The PNN is
mainly composed of hyaluronan, CSPG, link proteins
and tenascin R. The protein link between CSPG and
PNN is the key contributor to the plasticity inhibition
induced by PNN [112]. Furthermore, the diffusible tran-
scription factor Otx2 has been found to be transported
from the eye, promoting the onset of critical period plas-
ticity [113]. After amblyopic subjects played an action
video game, an increase in plasticity was observed [114].
The purpose of the PNN is to restrict the formation of
additional connections to the GABAergic neuronal net-
work. In a healthy adult, this restriction serves to main-
tain a stable set of parameters within the neuronal
circuits for normal daily functions. However, during in-
jury, it becomes a hinderance as the neuronal circuits
are still fixed but with a portion of the network being
damaged. This situation leads to the neurological and
psychological deficits observed. However, being able to
add new connections and modulate existing connections
in the inhibitory GABAergic network would instate the
ability of existing cortical maps to reorganize themselves
based on the demands exerted on the neuronal network,
thus enabling plasticity and providing a method for
functional recovery in the short and medium term.
Rehabilitation
Studies on neurorehabilitation began after the two world
wars to help treat brain-injured soldiers. There are two
main types of injuries sustained to the nervous system:
gunshot wounds and blast injuries. The injury profiles of
these two injuries are distinct. Gunshot wounds gener-
ally lead to more focal damage associated with SCI and
focal injuries in the brain. However, blast injuries and
blunt trauma [115] lead to more diffuse damage, such as
diffuse axonal injuries, or affect large areas within the
brain [116]. Therefore, functional recovery postinjury is
highly dependent on the mechanism of injury and treat-
ment of the damaged tissue accordingly. In the most se-
vere cases, such as in diffuse axonal injury, there is
widespread damage throughout the brain, resulting in
minimal functional tissue for the continued survival of
the individual. However, in many cases, there is still suf-
ficient tissue for survival. However, the quality of life in
these cases is often poor, as certain functions are lost,
depending on the extent of the brain damage, ranging
from paraplegia to anomia. Plasticity and neuroregenera-
tion alone are insufficient to achieve significant func-
tional recovery. Rehabilitation plays a key role in
ensuring that the potential generated by plasticity and
neuroregeneration can be guided to restore lost
functions.
As described above, when rehabilitation is conducted
after plasticity is induced, recovery of the rehabilitated
function is improved. However, there are barriers to
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translation when such rehabilitation is conducted in
humans as opposed to nonhuman mammals. In addition
to rehabilitation, humans require greater supraspinal in-
put to achieve outcomes similar to those of nonhuman
mammals, indicating the greater reliance of the spinal
cord on the brain [117]. In SCI, this supraspinal input is
often affected by denervation; however, when plasticity
and axonal regeneration are induced, detour circuits can
be formed through other neuronal tracts, such as the
propriospinal tract, within the spinal cord. Therefore,
great potential can be seen experimentally when re-
habilitation is combined with epidural stimulation,
pharmacological agents (serotonin and dopamine) and
neuromodulation to induce plasticity [118, 119]. Brand
et al. [120] demonstrated that voluntary control of loco-
motion was restored after a paralyzing spinal cord injury
upon rehabilitation and extensive plasticity induction.
However, this return of function could have been due to
the upright posture paradigm of the rehabilitation, as
opposed to being caused by the process of voluntary
movement. Overall, the general paradigm of functional
recovery from various forms of paralysis has been posi-
tive, with paralyzed patients beginning to move their
hands [121, 122], stand [123] and take steps [124, 125].
There has been a case where a paraplegic patient who
had a complete SCI for 3 years recovered stepping ability
after neuromodulation of the lumbosacral spinal net-
works to induce plasticity and neuroregeneration [126].
The upregulation of CNS regeneration for functional
recovery can also be achieved through exercise training.
Brain-derived neurotrophic factor (BDNF) expression
and rates of axonal sprouting are increased with tread-
mill training [127]. BDNF, neurotrophin-3 (NT-3) and
nerve growth factor (NGF) are among the key neuro-
trophic factors that influence the regeneration of the
nervous system. BDNF plays a role in stimulating the
growth of corticospinal tract neurons, NT-3 improves
the survival of those neurons, and NGF is an important
trophic factor for small diameter sensory neurons. Thus,
a thorough knowledge of their effects on specific neur-
onal populations is needed to guide effective targeting,
especially when used alongside other treatment options,
such as stem cell grafts and nerve bridges, to improve
plasticity and neuroregeneration [128]. The utilization of
these neurotrophic factors has led to functional recovery
in rodents [129] and primates [130]. Yang et al. [129] de-
veloped a novel matrix scaffold made up of chitosan and
slow-release NT-3, inducing endogenous neural stem
cells to proliferate, migrate and differentiate into neu-
rons while reducing posttraumatic inflammatory pro-
cesses such as glial scar formation. The reduction in
inflammatory processes is a key part of these treatments
in neuroregeneration, as Rosenzweig et al. [131] demon-
strated that the restorative effects of human stem cell
grafts in primates were successful only when the inflam-
matory process was mitigated. In experiments conducted
by Yang et al. [129], nascent neurons formed the basis of
an intermediate circuit that relayed ascending and de-
scending signals. Therefore, this regeneration of inter-
mediate relay neurons, coupled with rehabilitation and
induced plasticity, allows functional recovery of move-
ment to sites of focal injuries, especially to those in the
spinal cord.
In addition to these physiological methods of restoring
functional tissue to achieve functional recovery, bioelec-
tronic implants have been introduced that act to elec-
tronically relay messages across gaps in the nervous
system. These electronic implants can target circuits lo-
cated in the brain, midbrain, and spinal cord to improve
motor and autonomic function. They carry out their
function by augmenting the plasticity of the spared cir-
cuits and residual projections when coupled with re-
habilitation training programs. This approach is
especially useful when the area of damaged tissue is too
large to be bridged purely by physiological means. How-
ever, this method is currently limited by the short time-
span before the implant is rejected by the body’s
immune system through inflammatory processes such as
gliosis [132].
In humans, the sense of proprioception is considered es-
sential for coordinated movement, but not in smaller ani-
mals such as rodents. Taking this into account, Wagner
et al. [133, 134] devised a pattern-based electronic stimu-
lation, rather than the continuous stimulation reported in
previous studies, which coordinates with different phases
of the gait cycle. This ensures that the descending stimu-
lus signal is sent, while ascending proprioceptive stimula-
tion is also given the chance to be received. This approach
resulted in three individuals with SCI walking with min-
imal assistance that persisted post stimulation. This result
suggests that patterned electronic stimulation helps to
guide plasticity in the spinal cord effectively when com-
bined with rehabilitation to provide a synergistic effect for
functional recovery [135, 136]. Therefore, to be able to de-
velop effective functional recovery from electrical stimula-
tion combined with rehabilitation, patterned stimulation
is also necessary. To develop this pattern, there is a need
to understand the neurophysiological aspects of the neural
communication required for movements. For locomotion,
this understanding would include that of the gait cycle.
However, with the upper limbs, the range of movements
is significantly larger, given their greater utility. Thus,
Sburlea et al. [137] explored human grasping, represented
in neural, muscle and kinematic signals. On the basis of
this effort, additional work can be done to elicit similar
success for upper limb movements. In terms of restoring
psychological, cognitive and neurological function through
a similar concept, neurofeedback through real-time
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functional magnetic resonance imaging would be useful.
Stimulus patterns can be patterned according to the neu-
rofeedback received to generate a successful rehabilitation
protocols for recovering psychological, cognitive or neuro-
logical function [138].
There has been significant interest in the utilization of
robotic devices to conduct neurorehabilitation training.
Robotic devices serve the useful purpose of reducing the
load on therapists during ambulation and recording the
biomedical gait parameters more accurately than can be
accomplished with manual physical therapy [139]. How-
ever, a multicentered randomized control trial found
that robot-assisted training of the upper limbs after
stroke did not result in significantly better care for pa-
tients with moderate and severe upper limb functional
limitations than offered by traditional therapy. Forced
robotic gait training has also been implicated in altering
natural patterns of muscle activation, such as reduced
ankle flexion-extension and higher quadriceps-hamstring
activity in the swing phase compared to ambulation
training on a treadmill [140]. Therefore, robotic devices
are currently good aids for therapists to use for conduct
rehabilitation training but are not yet suitable as
complete replacements for usual therapy. Another inter-
esting development in rehabilitation training has been
the use of virtual reality to improve functional outcomes.
Table 2 Rehabilitative potential for different areas of the nervous system damaged by blast or gunshot injuries
Areas for rehabilitation
improvement
Affected area Methods that can be used with observed impacts
Movement disorders in
Parkinson’s Disease
Basal ganglia [144] • Long-term deep brain stimulation of the subthalamic nuclei
• Restorative effects of global structural and functional connectivity as a result of
plasticity and neuroregeneration [145]
• Stimulation of mesencephalic locomotor region [146] [analogous to the
pedunculopontine nucleus in humans [147]
Motor recovery after stroke Unilateral cervical
contusion [148]
• Vagal nerve stimulation
• Release of monoamines within cerebral cortex
• Promotes plasticity of neural circuits and enhances motor learning [148, 149].
• Activity-dependent plasticity also occurs [150].
Allodynia Mid-thoracic contusion SCI
[151]




• Intensive speech therapy [152, 153]
• Combined with pharmacological therapies [154–157]
• Combined with noninvasive brain stimulation [158–161].
• Results are promising, but sample sizes have been small [162].
Eating and swallowing Motor cortex • Sensory input essential as it drive changes in cortical circuitry [163].
• Neuromuscular stimulation induces plasticity changes [164].
Visual field and recognition Visual cortex • Restitutive capacity is limited [165]
• Compensatory mechanism are effective – shifting the visual field border towards the
hemianopic side in hemianopia to improve spatial orientation and mobility [165].
• New visual functions – enhancement of the resolution to make it greater than that
of the retina [165].
• Plasticity level in higher visual functions is unknown [166].
• Plasticity through cross-mode sharing of visual pathways with tactile or auditory
pathways through extensive training and practice [167].
Optic Nerve • Optic nerve with appropriate deletions of physiological “brakes” or additions of
“facilitators” can regenerate centrally from the retinal ganglion cells [47].
Cognitive (thinking, reasoning,
judgment and memory)
Frontal cortex • NF training can lead to positive memory function and normalization of pathological
brain activation patterns [168].
• Enriched environment promotes synaptic plasticity [169].
• Selective serotonin reuptake inhibitors administered acutely after brain injury may
induce plasticity similar to that seen in the critical period [170].
• Normal plasticity becomes dysfunctional postinjury, failing to confer neuroprotection
and to prevent further cell death. Therapies should target aspects of normal plasticity
that are altered postinjury [171].
Bowel and bladder control SCI above the sacrum • Early sacral neuromodulation following SCI reduces the extent of secondary injury
and maladaptive neural restricting [172].
• Further evidence needed to support this theory.
• EGFR inhibition promotes nerve regeneration in vitro and in vivo, with bladder
function restored in rodents [173].
Emotional control Fear memories • Inhibition of NgR1 can help with the recovery of emotional control postinjury [174,
175].
NF Neurofeedback, SCI Spinal Cord Injury, EGFR epidermal growth factor receptor, NgR1 Neuronal Nogo-66 receptor 1
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There have been mixed results in terms of the benefits
of Virtual Reality (VR). A systematic review found that
VR can lead to improved motor, psychological and cog-
nitive functions [141]. However, another review found
that there was no distinct relationship found between
immersion and improvement in motor recovery [142]. A
Cochrane review found that VR was not more beneficial
than conventional therapy in improving upper limb func-
tion [143]. Despite a range of conflicting opinions, it is im-
portant to recognize that the development of VR is still in
its infancy. Currently, VR can be used as an adjunct to
usual care to increase overall therapy time. As the technol-
ogy develops, further reassessments are necessary to de-
termine its effectiveness in improving functional recovery
in patients in rehabilitation programs.
In addition to the rehabilitation and the functional re-
covery of limb functions, plasticity and neuroregeneration
with rehabilitation can benefit other areas damaged by
gunshot wounds or bomb blasts, as indicated in Table 2.
These integrated treatment plans provide a means to
improve outcomes and recovery time following an injury
that previously would have been treated only palliatively.
This reduced recovery time and better recovery enable
veterans suffering from injuries to return to their daily
lives or even back to service. Looking beyond the current
horizon, if such integrated treatment plans can work for
injured individuals, it is possible to enhance the function
and/or reduce the workload of currently healthy soldiers
with integrated technologies [176, 177]. Leveraging our
understanding of relay circuits and the plasticity of the
brain, walking functions and limb movements can be
translated appropriately to an external exoskeleton when
proprioceptive sensory input is provided, with the result
of alleviating the soldier’s workload and reducing fatigue.
Furthermore, with a plastic brain, it may be possible to
learn new abilities and control external devices, thus im-
proving the functionality of a soldier.
Conclusions
Injury to the nervous system, as seen in SCI and TBI, has
been an area of concern because of its high incidence and
lack of clear and effective treatment strategies. We now
know the key molecular mechanisms that underlie the fail-
ure of nerve regeneration in the CNS and under conditions
of chronic injuries in PNS. This knowledge has enabled us
to use neuroregeneration and plasticity induction tech-
niques to stimulate the sprouting of nascent neurons and
modulate labile ones. Neurorehabilitation techniques have
also been developed to incorporate our current understand-
ing of movement, resulting in an enhanced recovery of
function by guiding nascent and labile neurons into the ap-
propriate end locations effectively. Further work needs to
be done on 1) understanding the balance between excita-
tory and inhibitory signals, 2) determining the effect of
injury on this balance and 3) identifying targets that can be
used to control this balance. This level of information
would enable accurate modulation of the neuronal network,
leading to activation of localized plasticity while preserving
stability in other areas. With regard to rehabilitation treat-
ments, we need to understand the pattern of upper limb
movements, as they have a higher degree of freedom than
lower limb gaits. Applying this knowledge to develop an ap-
propriate rehabilitative protocol while allowing for proprio-
ceptive feedback is the next step. Another effort that would
benefit the field involve developing a method to accurately
send descending outputs while preserving the ascending in-
puts in a 2-way flow of information to replace the 1-way
flow currently used.
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